Global Cell and Gene Therapy Manufacturing Services Market to Surge to $31.3 Billion by 2035, Driven by Regulatory Modernization

openPR.com (DataM Intelligence) Global

Overview

According to DataM Intelligence, the global cell and gene therapy manufacturing services market is projected to reach $8.77 billion in 2026, growing rapidly to $31.3 billion by 2035 with a Compound Annual Growth Rate (CAGR) of 15.2%. This market expansion is significantly propelled by an expanding cell therapy pipeline, increased reliance on CDMOs, and regulatory modernization, including FDA actions in 2026 enhancing CMC flexibility.

In Depth

This article provides an overview of a market research report published by DataM Intelligence via openPR.com.

Report Overview

The “Cell & Gene Therapy Manufacturing Services Market Size” report by DataM Intelligence offers a detailed analysis and future projections for the global cell and gene therapy manufacturing services market. The report covers key growth drivers, market segmentation, regional analysis, leading competitors, and technological trends, assessing long-term market dynamics from 2026 to 2035. It particularly emphasizes the impact of changes in the regulatory environment on market growth.

Key Findings

Key findings from the report include:

• Market Size and Growth Rate: The global cell and gene therapy manufacturing services market is projected to reach $8.77 billion in 2026. This market is expected to grow rapidly to $31.3 billion by 2035, demonstrating a Compound Annual Growth Rate (CAGR) of 15.2% over the forecast period.
• Growth Drivers:
  • Expanding Cell Therapy Pipeline: The increasing number of cell and gene therapy products in clinical development worldwide is driving a surge in demand for external manufacturing services.
  • Increased Reliance on CDMOs: Due to the complex and highly specialized expertise required for manufacturing cell and gene therapy products, many biopharmaceutical companies are intensifying their outsourcing to Contract Development and Manufacturing Organizations (CDMOs).
  • Regulatory Modernization: The modernization of the regulatory landscape, including actions taken by the U.S. Food and Drug Administration (FDA) in 2026, is a significant driver of market growth. This is expected to enhance flexibility in Chemistry, Manufacturing, and Controls (CMC) processes, thereby promoting efficient product development.

About the Publisher

DataM Intelligence is a global market intelligence provider offering market research and consulting services specialized in various niche markets. The company assists clients in making informed business decisions through detailed data analysis and strategic insights.

Get our weekly technology intelligence — free

Receive an infographic that lets you judge at a glance whether each field’s analysis report is worth reading.

Subscribe Free — Weekly Tech Intelligence

By subscribing, you’ll receive Troy-Technical’s weekly technology intelligence newsletter.

• Your email and selected fields are used only to deliver the newsletter.
• We never share your information with third parties.
• You can unsubscribe anytime via the link in each email.

See our Privacy Policy for details.

Agree & Continue ▶

Takes about a minute · Unsubscribe anytime